Enhancing Maternal Vaccine Knowledge and Uptake: the InTroDuce-Programme Trial

Launched by UNIVERSITI PUTRA MALAYSIA · Feb 3, 2025

Keywords

ClinConnect Summary

The InTroDuce-Programme Trial is a study aimed at helping pregnant women learn more about the Influenza and Tdap vaccines, which protect against serious illnesses. The researchers want to find out if a web-based educational program can improve women's understanding of these vaccines and encourage them to get vaccinated in the future. They will compare the results of women who use this program with those who receive standard prenatal care to see if the program makes a difference in their knowledge and vaccination intentions.

To participate in this study, women need to be at least 18 years old and pregnant, ideally before reaching 32 weeks of pregnancy. Participants will complete a web-based module that explains the importance and safety of vaccinations and addresses common concerns. After the educational session, they will answer questions to see how their knowledge and willingness to get vaccinated have changed. This trial is not yet recruiting participants, but it offers an exciting opportunity for pregnant women to become more informed about vaccinations that can help protect both them and their babies.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women aged 18 years and older
• • Before or equal to 32 weeks of gestation as we need to follow-up the patients again at 36 weeks of gestation before delivery occurs.
• • Able to understand and consent to participation in the study.
• Exclusion Criteria:
• • Pregnant women with severe anaphylactic or allergic reactions to previous dose of influenza or Tdap vaccination.
• • Non-Malaysian